BioSpace News Archive

Hollister Incorporated and KMT Medical celebrate Founder’s Day , recognizing the 100th anniversary of their parent company, The Firm of John Dickinson Schneider Inc.

The Sonic Fund II, L.P., which beneficially owns approximately 6.8% of the outstanding common stock of Adverum Biotechnologies, Inc., reminded stockholders to make their voices heard at the Company’s upcoming 2021 Annual Meeting of Stockholders, which will be held on Wednesday, May 12, 2021.

National Imaging Solutions, a recognized leader in medical imaging and radiology solutions, announced it has acquired DynaRad – the oldest manufacturer of portable x-ray systems in the US.

Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a leading clinical-stage messenger RNA medicines company focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases, today announced its financial results for the first quarter ended March 31, 2021 and provided corporate updates.

Today, the U.S. Food and Drug Administration expanded the emergency use authorization (EUA) for the Pfizer-BioNTech COVID-19 Vaccine for the prevention of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to include adolescents 12 through 15 years of age

Medicure Inc., a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market, reported its results from operations for the quarter ended March 31, 2021.

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced today that the U.S. Food and Drug Administration (FDA) has expanded the Emergency Use Authorization (EUA) for their COVID-19 vaccine to include individuals 12 to 15 years of age.

Seegene Inc., a leading molecular diagnostics firm said its German subsidiary, Seegene Germany GmbH is taking part in the government’s Back-to-School program called the “Lolli-Test,” a starting point in returning our daily lives back to normalcy.

Surgalign Spine Technologies, a global medical technology company focused on elevating the standard of care by driving the evolution of digital surgery, reported operating results for the first quarter of 2021.

AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company, today announced that it will release first quarter financial results after market close on Monday, May 17, 2021